
Athira Pharma ATHA
Athira Pharma Total Current Liabilities | ATHA
Annual Total Current Liabilities Athira Pharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.5 M | 13.1 M | 28.8 M | 21.4 M | 9.29 M | 4.4 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 47.5 M | 4.4 M | 20.8 M |
Total Current Liabilities of other stocks in the Biotechnology industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Celsion Corporation
CLSN
|
4.62 M | - | -6.63 % | $ 13.9 M | ||
|
Synthetic Biologics
SYN
|
10 M | - | 1.32 % | $ 16.2 M | ||
|
Dynavax Technologies Corporation
DVAX
|
78.6 M | - | - | $ 2.02 B | ||
|
I-Mab
IMAB
|
412 M | - | - | $ 866 M | ||
|
Corner Growth Acquisition Corp.
COOL
|
30.2 K | - | -0.89 % | $ 114 M | ||
|
AgeX Therapeutics
AGE
|
3.56 M | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | ||
|
Qilian International Holding Group Limited
QLI
|
41.6 M | - | -6.08 % | $ 184 M | ||
|
Happiness Biotech Group Limited
HAPP
|
2.47 M | - | 1.35 % | $ 17.8 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | ||
|
Завод ДИОД
DIOD
|
105 M | - | - | - | ||
|
Galera Therapeutics
GRTX
|
645 K | - | -32.59 % | $ 7.61 M | ||
|
Hepion Pharmaceuticals
HEPA
|
299 K | - | -18.79 % | $ 39.3 K | ||
|
ARCA biopharma
ABIO
|
15.4 M | - | 1052.0 % | $ 415 M | ||
|
Codexis
CDXS
|
25.3 M | $ 1.46 | 2.82 % | $ 127 M | ||
|
Ardelyx
ARDX
|
88.6 M | $ 3.78 | 1.89 % | $ 911 M | ||
|
Arcutis Biotherapeutics
ARQT
|
130 M | $ 23.9 | 1.01 % | $ 3.04 B | ||
|
Assembly Biosciences
ASMB
|
48.8 M | $ 36.6 | 1.3 % | $ 410 M | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
42.3 M | - | -1.58 % | $ 28.1 M | ||
|
Adial Pharmaceuticals
ADIL
|
1.4 M | $ 7.12 | 6.91 % | $ 4.76 M | ||
|
Generation Bio Co.
GBIO
|
35.1 M | - | - | $ 344 M | ||
|
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.33 M | - | -4.36 % | $ 27 M | ||
|
Gracell Biotechnologies
GRCL
|
221 M | - | - | $ 3.37 B | ||
|
Axsome Therapeutics
AXSM
|
379 M | $ 206.68 | 0.16 % | $ 10.3 B | ||
|
GlycoMimetics
GLYC
|
36.1 M | - | 9357.83 % | $ 1.01 B | ||
|
AnaptysBio
ANAB
|
38.6 M | $ 56.8 | 0.94 % | $ 1.63 B | ||
|
AVROBIO
AVRO
|
9.67 M | - | 1083.1 % | $ 745 M | ||
|
BioMarin Pharmaceutical
BMRN
|
759 M | $ 66.53 | 0.15 % | $ 12.8 B | ||
|
BeiGene, Ltd.
BGNE
|
1.83 B | - | 0.49 % | $ 251 B | ||
|
AIkido Pharma
AIKI
|
1.61 M | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | ||
|
Aptose Biosciences
APTO
|
9.31 M | - | -45.71 % | $ 1.2 M | ||
|
Bicycle Therapeutics plc
BCYC
|
57 M | $ 4.3 | 1.42 % | $ 298 M | ||
|
AlloVir
ALVR
|
9.71 M | - | 4.14 % | $ 49.1 M | ||
|
ChromaDex Corporation
CDXC
|
19.9 M | - | -0.88 % | $ 598 M |